CSIMarket
 
Apogee Therapeutics Inc   (NASDAQ: APGE)
 

Apogee Therapeutics Inc's Customers Performance

APGE



 
APGE's Source of Revenues

List of APGE Customers




for the same period Apogee Therapeutics Inc

List of APGE Customers





Apogee Therapeutics Inc's Comment on Sales, Marketing and Customers





  News about Apogee Therapeutics Inc Contracts

Apogee Pharmaceuticals Reports Encouraging Results for APG777, a Groundbreaking Therapy for Inflammatory Diseases, with Potential for Best-in-Class Profile and Extended Treatment Intervals.

Apogee Announces Promising Interim Results from Phase 1 Trial for APG777: A Breakthrough in the Treatment of Inflammatory DiseasesApogee Pharmaceuticals, a leading biotech company, has reported positive interim results from its Phase 1 healthy volunteer trial for APG777, a novel half-life extended anti-IL-13 antibody. This groundbreaking treatment shows great potential for the management of atopic dermatitis and other inflammatory diseases, surpassing trial s ahead of schedule. The impressive half-life of approximately 75 days positions APG777 as a potential best-in-class therapeutic option, with the ability to deliver improved clinical responses through higher induction exposures and less frequent maintenan...












APGE's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Apogee Therapeutics Inc 10,190.15 0.00 -274.62 261
SUBTOTAL 0.00 0.00 0.00 -

Sources: Apogee Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Apogee Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Apogee Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.